/

Empresas

Fr

No verificado

Fresenius Kabi

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaSaludSanidad

39 Comunicados de prensa

Ver todos los comunicados de prensa

04/08/2026

Fresenius Kabi Issues Voluntary Nationwide Recall of One Lot of Morphine Sulfate Injection, USP in a Simplist® Prefilled Syringe Due to Labeling Mix-up

Fuente

Editor

1.00

0

03/08/2026

Industria

Ciencia

Higiene alimentaria

Medicina - Varios

Biotecnología

Sanidad

Salud

Farmacéutica

Fresenius Announces FDA Approval of Rituximab Biosimilar for the U.S. Market

Fuente

Editor

1.00

0

31/07/2026

Industria

Biotecnología

Higiene alimentaria

Sanidad

Salud

Farmacéutica

Ciencia

Medicina - Varios

Fresenius Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate

Fuente

Editor

1.00

0

09/04/2026

Industria

Biotecnología

Farmacéutica

Sanidad

Salud

Higiene alimentaria

VIH, SIDA y enfermedades autoinmunes

CMS Grants Fresenius Kabi COVID-19 Indication-Specific HCPCS Codes for Tyenne® (tocilizumab-aazg)

Fuente

Editor

1.00

0

20/01/2026

Fresenius Kabi Recognized as a Top Employer in the United States for the Fourth Consecutive Year

Fuente

Editor

1.00

0

14/01/2026

Multimedia

Industria

Higiene alimentaria

Biotecnología

Salud

Farmacéutica

Sanidad

Oncología

Mercado laboral

Fresenius Kabi, TQ Therapeutics Announce Cell Therapy Technology Agreement

Fuente

Editor

1.00

0

06/01/2026

Fresenius Kabi Introduces New Presentation of Otulfi® (ustekinumab-aauz), a Biosimilar to Stelara®

Fuente

Editor

1.00

0

18/12/2025

Fresenius Kabi Introduces First-Ever Rocuronium Bromide Injection Stable at Room Temperature

Fuente

Editor

1.00

0

02/12/2025

Fresenius Kabi Expands Operating Room Portfolio with New Simplist® Prefilled Syringes

Fuente

Editor

1.00

0

24/11/2025

Fresenius Kabi Introduces Dalbavancin for Injection (for single-dose regimen use only)

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0